Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma.
Saved in:
| Title: | Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma. |
|---|---|
| Authors: | Stewart AK; Division of Hematology-Oncology, Mayo Clinic, Phoenix, AZ, USA. Stewart.Keith@mayo.edu., Krishnan AY; Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope Medical Center, Duarte, CA, USA., Singhal S; Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA., Boccia RV; Center for Cancer and Blood Disorders, Bethesda, MD, USA., Patel MR; Florida Cancer Specialists, Sarasota, FL, USA.; Sarah Cannon Research Institute, Nashville, TN, USA., Niesvizky R; Multiple Myeloma Center, New York Presbyterian Hospital-Cornell Medical Center, New York, NY, USA., Chanan-Khan AA; Division of Hematology & Oncology, Mayo Clinic, Jacksonville, FL, USA., Ailawadhi S; Division of Hematology & Oncology, Mayo Clinic, Jacksonville, FL, USA., Brumm J; Genentech, Inc., South San Francisco, CA, USA., Mundt KE; Genentech, Inc., South San Francisco, CA, USA., Hong K; Genentech, Inc., South San Francisco, CA, USA., McBride J; Genentech, Inc., South San Francisco, CA, USA., Shon-Nguyen Q; Genentech, Inc., South San Francisco, CA, USA., Xiao Y; Genentech, Inc., South San Francisco, CA, USA., Ramakrishnan V; Genentech, Inc., South San Francisco, CA, USA., Polson AG; Genentech, Inc., South San Francisco, CA, USA., Samineni D; Genentech, Inc., South San Francisco, CA, USA., Leipold D; Genentech, Inc., South San Francisco, CA, USA., Humke EW; Genentech, Inc., South San Francisco, CA, USA., McClellan JS; Genentech, Inc., South San Francisco, CA, USA., Berdeja JG; Sarah Cannon Research Institute, Nashville, TN, USA. |
| Source: | Blood cancer journal [Blood Cancer J] 2019 Feb 04; Vol. 9 (2), pp. 17. Date of Electronic Publication: 2019 Feb 04. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
